 |
|
|
 |
Hi ,
Last week in Washington D.C., we hosted a Bioeconomy Showcase that was informative and eye-opening for members of the U.S. Congress. An array of synthetic biology companies showcased their tangible innovations, underscoring the importance of the bioeconomy and the vast number of industries it touches—from agriculture to building supplies to consumer products.
Companies in the spotlight:
We thank Congressional Reps Jim Baird (R-IN 4th District), Young Kim (R-CA 40th District), and John Garamendi (D-CA 8th District) for their attendance, insights, and support of biotechnology innovation.
To read a wrap-up about the event, check out our latest Insights article:
|
 |
Top: Group photo. Bottom left: J. Casey Lippmeier (Conagen), Representative Young Kim (CA-40), and John Cumbers. Bottom right: Suveen Sahib (K18 Hair), Genét Garamendi (Checkerspot), Representative John Garamendi (D-CA08), Representative Jim Baird (IN-04), and John Cumbers.
To get a better understanding of industry perspectives on the U.S. bioeconomy and the U.S. biomanufacturing sector, the Federation of American Scientists interviewed Dr. Sarah Richardson, the CEO of MicroByre. MicroByre is a climate-focused biotech startup that specializes in providing specialized bacteria based on the specific fermentation needs of its clients.
|
 |
Sarah Richardson, CEO of MicroByre, at SynBioBeta.
With less than two weeks to go until the 2023 Chemistry Nobel Prize is announced, Web of Science provider Clarivate has published its annual list of citation laureates. This year, the list includes Bioengineer James Collins from the Massachusetts Institute of Technology (MIT), US, biologist Michael Elowitz from Caltech, US, and theoretical and experimental biologist and physicist Stanislas Leibler at Princeton, US, who were selected for their ‘pioneering work’ on synthetic gene circuits, which established the field of synthetic biology.
|
News:
|
|
|
|
|
|
|
|
Other news:
|
|
Regards,
John
---
John Cumbers
CEO, SynBioBeta
|
Who's hiring?
|
|
|
|
|
|
|
